Katie’s Dividend Growth Portfolio

Now that the first purchase for the DTA Income Builder Portfolio is in the books, I thought folks might be interested in seeing an example of what this enterprise can become.

Although I always strive to provide information any investor can use, the IBP is mostly being aimed at relatively new Dividend Growth Investing practitioners – people who want to build a durable, reliable, growing income stream for years (or decades) down the road.

As stated in its business plan, the Income Builder Portfolio is a long-term project. Still, looking at an actual portfolio that was started by a DGI newcomer fewer than 3 years ago could help fellow investors see the possibilities.

Heeeeere’s Katie!

My daughter is 31 years old. She lives in Seattle, recently married a great guy named Ben and is employed in the mortgage industry.

During her 20s, Katie worked at Starbucks (SBUX).

She started as a barista when she was in college, and she gradually moved up the food chain to shift supervisor, assistant store manager and store manager.

While with the company, she accumulated some Starbucks stock in her 401(k) plan; she also invested in a couple of mutual funds her plan offered.

By 2015, she felt she had enough additional cash saved to open a Roth IRA account.

Her first Roth purchase was Baxter (BAX). This brief conversation we had back then tells the story of how she came to own the health-care company …

Katie: “I think Baxter would be a good stock for my Roth.”

Me: “Maybe, but you really shouldn’t buy it just because your dog’s name is Baxter.”

Katie: “Yeah, but Baxter is a good company, right? Don’t you own it?”

Me: “Well, yeah.”

Katie: “OK then. Baxter it is!”

I guess she’s fortunate that her dog’s name wasn’t Radio Shack!

Anyway, I am NOT advocating the strategy of using a pet’s name to determine stocks to buy. Katie got away with it that one time because I actually knew the company pretty well, and I gave her idea a thumbs-up.

Since then, I have helped her learn how to evaluate stocks based upon their fundamentals. I think she has done an outstanding job, as you’ll soon see.

Her second Roth buy, also in 2015, was Costco (COST).

Having left Starbucks for another employer, Katie in 2016 rolled over everything in her 401(k) – including a fairly large mutual fund position – to an IRA she established at a brokerage. She sold the fund and began putting the proceeds to work.

That year, she bought shares of Boeing (BA), Amgen (AMGN), Altria (MO), 3M (MMM), Visa (V), Pepsi (PEP), Johnson & Johnson (JNJ) and General Mills (GIS). Those eight positions were equally weighed, meaning she bought about the same dollar amount of each.

In 2017, she dispersed the last of the available cash in her rollover IRA with two relatively small buys, Alphabet (GOOGL) and TJX (TJX), giving her portfolio 13 companies. She also purchased a few more Costco shares in her Roth.

Along the way, she reinvested all dividends back into the stocks that paid them, a process informally called “dripping.”

The following table shows Katie’s portfolio now, arranged in order of total-return gain of each position. All data, lifted off of her brokerage account page, is through market close Friday, Jan. 19. “MRR” in the last column refers to each company’s most recent dividend raise.

Although I am not going to discuss each of Katie’s holdings at length, here are a few items of interest:

  • Katie’s income grew about 13% from 2016 to 2017. As shown in the last column of the table, most of her holdings have received robust dividend increases.
  • She bought Boeing the day regulators announced an investigation into the company’s accounting practices – news that caused share prices to pull back sharply. That timely buy, followed by a lengthy upswing in Boeing’s business that has continued to the present, resulted in her BA stake more than tripling in less than two years. Wow!
  • Another “value play” for Katie was Amgen. As I explained in a recent article, biotechnology companies like Amgen can have significant price swings, and she got her AMGN during a major ebb.
  • At the other end of the spectrum, Visa, 3M, Costco and Alphabet were considered “overvalued” by most observers. Katie bought them anyway because she believed they were high-quality companies with wide moats (competitive economic advantages) and excellent business models. They have continued to outperform the market.
  • Even though Alphabet, the parent of Google, does not pay a dividend, Katie wanted to own it for its growth and potential. Nice call!

  • No “pure” DGI practitioner would touch a company such as GOOGL, but investors should stay open-minded. I don’t believe that owning one non-income-producing company in a 13-stock portfolio somehow nullifies the DGI strategy.
  • While saving for her wedding and a house, Katie has put very little money into her Roth IRA lately. She is still investing in mutual funds in her new employer’s 401(k) plan, and she does hope to start allocating more money to her Roth soon. Eventually, she wants to own many more stocks, especially adding to under-represented sectors.
  • Katie’s husband has worked at Microsoft (MSFT) for several years and owns a considerable amount of his company’s stock. That’s one reason Katie has little technology exposure.
  • It could be argued that her Boeing and Starbucks positions have become too large in relation to the others, and therefore she should rebalance. I don’t think it’s a major problem, however. For one thing, her portfolio is not that large. For another, as time goes on, new investments in other stocks will help balance things out.

According to Simply Safe Dividends, Katie’s overall portfolio yield is only a tick above 2%. Retirees and near-retirees likely would consider that inadequate, but a 30-something has many years to grow her or his income stream.

As you can see from the above Simply Safe Dividends graphic, her portfolio’s dividend stream is very safe (88 on the 1-to-100 scale), and its dividend growth is well above average. (I typically pay little attention to yield on cost and beta, but SSD provides those figures so I thought I’d pass them along.)

Nobody’s Perfect

TJX has tread water since Katie bought it, and General Mills has been a “loser.” That’s life in the big-girl world of investing.

It would be great if every company owned by each of us could experience amazing results every single year, but that’s unrealistic. No investor is perfect, nor does any investor need to be perfect to succeed spectacularly.

Despite underperformance by two of Katie’s 13 positions, her overall portfolio is up more than 50% since inception.

Beyond that, each of her 12 income-producing stocks has grown its dividends. Her one total-return loser, General Mills, has paid dividends without interruption or reduction, for 119 consecutive years.

Wrapping Things Up

So, what does all of this have to do with the Income Builder Portfolio?

Well, what Katie has built so far serves as a pretty good example of how a newcomer to stock investing in general, and DGI in particular, can put together a successful portfolio filled with high-quality names.

The IBP already made AMGN its first purchase, and I wouldn’t be surprised if several of Katie’s other holdings end up in the Income Builder Portfolio, too.

Position #2 for the IBP will be selected later this week.

— Mike Nadel

Warren Buffett Went All-in In a Sector He Swore He'd Never Touch. Will you? [sponsored ad]
Buffett could see this new asset run 2,524% in 2018. And he's not the only one... Shark Tank Personality Mark Cuban says "it's the most exciting thing I've ever seen."… Facebook CEO Mark Zuckerberg threw down $19 billion to get a piece... Microsoft Founder Bill Gates wagered $26 billion trying to control it... What is it? It's not gold, crypto or any mainstream investment. These mega-billionaires have bet the farm it's about to become the most valuable asset on Earth. And if you act fast, you could see tremendous returns before the year is up. Click here for immediate details.

Disclosure: I own BA, V, MMM, SBUX, AMGN, COST, JNJ, PEP, MO and GIS. Regrettably, I sold BAX in 2016. The purpose of this article was not to recommend purchase of any company’s stock. As always, each investor should conduct her or his own due diligence.